| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
|---|
|
| | | IP | | | Fortam 1 g | Durchstechflasche(n) | 9.69 | 26.95 | 10 % | | Powder for injection- or infusion solution: Ceftazidimum 1 g | Sandoz
Pharmaceuticals AG | A / SL | FB | | G |  |
| | | IP | | | Fortam 2 g | Durchstechflasche(n) | 16.73 | 34.60 | 10 % | | Powder for injection- or infusion solution: Ceftazidimum 2 g | Sandoz
Pharmaceuticals AG | A / SL | FB | | G | |
| | | IP | | | Fortam 500 mg | Durchstechflasche(n) | 5.29 | 15.00 | 10 % | | Dry substance: Ceftazidimum 500 mg | Sandoz
Pharmaceuticals AG | A / SL | FB | | G | |
|
| L | | IP | | | Rocephin 1 g i.v. | 1 + | 11.22 | 21.10 | 10 % | | Lyophilisate and solvent: Ceftriaxonum 1 g | Roche Pharma
(Schweiz) AG | A / SL / SO | FB | | G | |
| L | | IP | | | Rocephin 2 g i.v. | Durchstechflasche(n) | 23.41 | 41.05 | 10 % | | Lyophilisate: Ceftriaxonum 2 g | Roche Pharma
(Schweiz) AG | A / SL / SO | FB | | G | |
| L | | IP | | | Ceftriaxon Labatec 2 g
i.v. | 2 g | 9.90 | 27.20 | 10 % | | Dry substance: Ceftriaxonum 2000 mg | Labatec Pharma SA | A / SL / SG | FB | | G | |
| L | | IP | | | Ceftriaxon Labatec 2 g
i.v. | 10 x 2 g | 84.15 | 107.95 | 10 % | | Dry substance: Ceftriaxonum 2000 mg | Labatec Pharma SA | A / SL / SG | FB | | G | |
| L | | IP | | | Ceftriaxon Labatec 1 g
i.v./i.m. | 1 g | 6.15 | 15.90 | 10 % | | poudre pour solution injectable: Ceftriaxonum 1000 mg | Labatec Pharma SA | A / SL / SG | FB | | G | |
| L | | IP | | | Ceftriaxon Labatec 1 g
i.v./i.m. | 10 x 1 g | 52.25 | 73.25 | 10 % | | poudre pour solution injectable: Ceftriaxonum 1000 mg | Labatec Pharma SA | A / SL / SG | FB | | G | |
| L | | IP | | | Rocephin 1 g i.m. | 1 + | 11.22 | 28.60 | 10 % | | Lyophilisate and solvent: Lidocaini Hydrochloridum Anhydricum 35mg / 3.5ml
Lyophilisate and solvent: Ceftriaxonum 1 g | Roche Pharma
(Schweiz) AG | A / SL | FB | | G | |
| L | | IP | | | Rocephin 500 mg i.v. | 1 + | 11.15 | 28.55 | 10 % | | Lyophilisate and solvent: Ceftriaxonum 500 mg | Roche Pharma
(Schweiz) AG | A / SL | FB | | G | |
| | | IP | | | Ceftriaxon Lagap 500 mg
i.v. | | PR | PR | k.A. | | Polvere per soluzione iniettabile: Ceftriaxonum 500 mg | Lagap SA | A | FB | | G | |
| | | IP | | | Ceftriaxon Lagap 500 mg
i.v. | 10 | PR | PR | k.A. | | Polvere per soluzione iniettabile: Ceftriaxonum 500 mg | Lagap SA | A | FB | | G | |
| | | IP | | | Ceftriaxon Lagap 1000 mg
i.v./i.m. | | PR | PR | k.A. | | Polvere per soluzione iniettabile: Ceftriaxonum 1000 mg | Lagap SA | A | FB | | G | |
| | | IP | | | Ceftriaxon Lagap 1000 mg
i.v./i.m. | 10 | PR | PR | k.A. | | Polvere per soluzione iniettabile: Ceftriaxonum 1000 mg | Lagap SA | A | FB | | G | |
| | | IP | | | Ceftriaxon Lagap 2000 mg
i.v. | | PR | PR | k.A. | | Polvere per soluzione per infusione: Ceftriaxonum 2000 mg | Lagap SA | A | FB | | G | |
| | | IP | | | Ceftriaxon Lagap 2000 mg
i.v. | 10 | PR | PR | k.A. | | Polvere per soluzione per infusione: Ceftriaxonum 2000 mg | Lagap SA | A | FB | | G | |
| | | IP | | | Ceftriaxon Labatec 250 mg
i.m. | 10 x 250 mg | PR | PR | k.A. | | poudre pour solution injectable: Ceftriaxonum 250 mg | Labatec Pharma SA | A | FB | | G | |
| | | IP | | | Ceftriaxon Labatec 500 mg
i.v. | 10 x 500 mg | PR | PR | k.A. | | poudre pour solution injectable: Ceftriaxonum 500 mg | Labatec Pharma SA | A | FB | | G | |
| | | IP | | | Ceftriaxon OrPha 1 g | 1 g | 11.50 | 25.50 | k.A. | | | OrPha Swiss GmbH | A | FB | | G | |
| | | IP | | | Ceftriaxon OrPha 2 g | 2 g | 17.00 | 35.90 | k.A. | | | OrPha Swiss GmbH | A | FB | | G | |
| | | IP | | | Ceftriaxon OrPha 1 g | 5 x 1 g | PR | PR | k.A. | | | OrPha Swiss GmbH | A | FB | | G | |
| | | IP | | | Ceftriaxon OrPha 2 g | 5 x 2 g | PR | PR | k.A. | | | OrPha Swiss GmbH | A | FB | | G | |
|
| | | IP | CI | | Cefpodoxim Sandoz 100 | 10 Tablet(s) | 5.10 | 14.80 | 10 % | | Coated tablets: Cefpodoximum 100 mg | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Cefpodoxim Sandoz 100 | 20 Tablet(s) | 8.99 | 26.20 | 10 % | | Coated tablets: Cefpodoximum 100 mg | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Cefpodoxim Sandoz 200 | 10 Tablet(s) | 10.22 | 27.55 | 10 % | | Coated tablets: Cefpodoximum 200 mg | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Cefpodoxim Sandoz 200 | 20 Tablet(s) | 18.35 | 36.35 | 10 % | | Coated tablets: Cefpodoximum 200 mg | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G | |
|
| L | | IP | | | Zavicefta | 10 | 1151.31 | 1268.55 | 10 % | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: 2 Active Agents | Pfizer AG | A / SL | FB | | G | |
